BPG is committed to discovery and dissemination of knowledge
Minireviews Open Access
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
Artif Intell Cancer. Sep 8, 2026; 7(1): 118079
Published online Sep 8, 2026. doi: 10.35713/aic.v7.i1.118079
From gastric cancer prevention to global health care, this is the way to implementing artificial intelligence in medicine
Sergey M Kotelevets, Department of Propaedeutics of Internal Medicine, North Caucasus State Academy, Cherkessk 369000, Karachay-Cherkess Republic, Russia
ORCID number: Sergey M Kotelevets (0000-0003-4915-6869).
Author contributions: Kotelevets SM contributed to this paper, designed the overall concept and outline of the manuscript, contributed to the design of the manuscript, contributed to the writing and editing the manuscript, illustrations, and review of literature.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Sergey M Kotelevets, MD, Professor, Department of Propaedeutics of Internal Medicine, North Caucasus State Academy, Stavropolskaya Street 36, Cherkessk 369000, Karachay-Cherkess Republic, Russia. smkotelevets@mail.ru
Received: December 23, 2025
Revised: January 15, 2026
Accepted: February 3, 2026
Published online: September 8, 2026
Processing time: 253 Days and 15.8 Hours

Abstract

The use of artificial intelligence (AI) models for gastric cancer prevention shows promise beyond traditional diagnostic approaches. Modern digital technologies can be applied to global healthcare. The implementation of deep machine learning has significantly increased the efficiency of computer vision. The introduction of AI is very effective in the field of diagnostic recognition of pathology in endoscopic, radiological and histological images. Robotic surgery has good development prospects. Also, many methods of treating diseases are implemented using AI technologies. Comparative studies of the effectiveness of a human doctor and AI have a high level of evidence. Comparative studies report high levels of performance for AI vs human clinicians in selected tasks, although evidence varies by task and dataset. AI demonstrates higher efficiency than 5-10 highly qualified experts in many areas of medicine. The main areas of medicine actively use AI: Diagnostic recognition of X-ray computed tomographic and magnetic resonance images, endoscopic and histological patterns. The use of AI has begun in the field of targeted treatment. The development of robot-associated surgery continues. There is a good prospect for using AI not only for recognizing X-ray computer images, in endoscopy, histology and targeted treatment, but also for subjective methods of examining patients. For example, the development of AI models for questioning patients by correspondence or conversation between the interlocutor - a doctor and the interlocutor-a patient has begun. The number of assistants (interlocutors, digital agents) can be more than two. The language of communication can also be any.

Key Words: Artificial intelligence; Deep machine learning; X-ray computer images; Magnetic resonance images; Endoscopic; Histological patterns; Targeted treatment; Robot-associated surgery

Core Tip: Modern digital technologies can be applied in global healthcare. The introduction of deep machine learning has significantly increased the effectiveness of computer vision. Pathology recognition in endoscopic, radiological, and histological images holds promise in the diagnosis of internal diseases. Physical diagnostic methods (visual examination, palpation, percussion, and auscultation) using artificial intelligence (AI) have demonstrated high diagnostic effectiveness. Comparative studies of the effectiveness of human physicians and AI have a high level of evidence. Development of AI models for interviewing patients via correspondence or in a conversational format between a physician and a patient has begun.



INTRODUCTION

The topic of developing, implementing, and using digital technologies is rapidly spreading across all areas of healthcare and medical science. The rapid growth in the number of publications on artificial intelligence (AI) in medicine demonstrates that global healthcare is poised for the progressive implementation and use of machine learning models and deep learning in preventive, diagnostic, therapeutic, and prognostic medical technologies[1,2].

POSSIBILITIES OF IMPLEMENTING MACHINE LEARNING IN MEDICINE AT THE PRESENT STAGE

AI is being rapidly developed and integrated into clinical practice. Few areas of medicine remain untouched by AI. Therapeutics, surgery, diagnostics, medical statistics, health management, biomedical research, and medical education increasingly employ digital technologies, including convolutional, recurrent, and graph neural networks[3]. AI facilitates improvements in the efficiency and quality of medical care across diverse healthcare systems and supports the advancement of personalized and preventive medicine[4]. Although AI applications in colorectal surgery remain preliminary, AI-enhanced robotic surgery has the potential to transform surgical practice in the coming years, as suggested by recent systematic reviews[5]. Nevertheless, AI-assisted robotic systems do not supplant the clinician–patient relationship; procedures such as spinal surgery continue to require meticulous perioperative care and empathic communication, which influence postoperative recovery[6]. AI can assist decision-making in emergency surgery, yet the deployment of digital technologies in emergency settings raises complex legal and ethical issues. Clinical decisions in the operating room and at the bedside are unlikely to be made without physician oversight[7]. The transformation of step-by-step methodologies with input from the most experienced experts plays a primary role during revolutionary changes. International professional societies can establish consensus committees to transform methodology and develop protocols, practical recommendations, indications and contraindications, and their systematic updates while considering legal and ethical standards for implementing digital technologies in medicine[8]. There is extensive practical experience in robotic surgery in pediatrics and urology[9,10]. The advantages of robotic surgery over laparoscopic liver surgery remain debated. With improved tactile feedback, AI will further enhance robotic capabilities in the future[11]. The number of scientific publications on robotic surgery grows annually, with the United States leading in publications and citations. Leading clinical areas for robotic surgery include gastrointestinal, gynecological, pulmonary, and thyroid diseases. AI combined with robotic surgery will become a key trend in modern surgical methodology[12]. AI is in high demand for training residents in robotic surgery methodology[13]. Robotic endovascular surgery often replaces traditional endovascular technologies in cardiac surgery, including atrial septal defect repair, left atrial myxoma resection, and mitral valve repair[14]. The methodology for implementing AI in robotic surgery includes a standard set of tools. As in other areas, computer vision for image recognition is carried out using deep learning. Choksi et al[15] used 211 videos to train a robot; the model was tested on ten robotic inguinal hernia procedures[15]. Robotic-assisted lymphatic supermicrosurgery has gained popularity recently, offering advantages in dexterity, precision, and ergonomics[16]. There is growing interest in AI-assisted robotic approaches in neurosurgery. A systematic review of computer vision methodologies found frequent use of convolutional neural networks (65%); recurrent neural networks and hybrid architectures also demonstrate excellent results[17]. AI and robot-assisted surgery have shown high efficiency in transplantology. Modern robotic digital technologies can be used not only for the most complex surgical operations in transplantology, but can also be used for training transplant surgeons[18]. The innovative robotic dental implant system is successfully implemented in oral implant surgery. The robotic arm of the EC66 model has six degrees of freedom. It operates using optical navigation technology and digital correction of the implant direction. The robotic arm is carefully calibrated. The eyes of the robotic system are also calibrated. Optimized calibration methods allow for increased angular accuracy and therefore the innovative robotic system is more efficient than a human hand[19]. Pharmacotherapy methods are being transformed by AI implementation. Challenges in drug discovery stem from multifactorial heterogeneity, including genetic polymorphism and diverse genetic risks. AI based on deep learning significantly facilitates the search for genetic targets. Promising results are expected in pharmacotherapy for arterial hypertension and drug discovery for dementia[20,21]. AI shows potential for predicting treatment outcomes in breast cancer[22] and atrial fibrillation[23]. In the pharmaceutical sector, AI reduces drug development costs, enables prediction of therapeutic outcomes, models pharmacokinetic profiles, and assesses drug toxicity[24]. AI has great potential to improve personalized treatment, enhance targeted pharmacotherapy, and individualize radiotherapy dosing[25]. Treatment stratification and gene therapy should follow personalized-medicine principles. AI may effectively support new treatments for chronic lung diseases, gene therapies for cystic fibrosis, chronic obstructive pulmonary disease, asthma, idiopathic pulmonary fibrosis, and acute respiratory distress syndrome[26]. AI-based image analysis for recognizing polyploid giant cancer cells in breast cancer has been successfully used to predict chemoresistance, metastasis, and survival based on biomarker analysis[27]. Using AI to identify oncogenic variants improves targeted therapy effectiveness in precision oncology[28]. Integrating AI into clinical decision support systems enhances strategies to overcome antibiotic resistance during antibacterial therapy in severe infectious and septic diseases[29]. A methodology combining AI-guided analytics and nanotechnology enables better personalization of postoperative pain management protocols in spinal surgery[30]. AI has made significant progress in the treatment of surgical and medical patients, and even greater progress has been achieved in disease diagnosis.

USING AI IN DISEASE DIAGNOSTICS AND REHABILITATION

The methodology of diagnostic image recognition obtained during X-ray, magnetic resonance imaging, computed tomography, endoscopic, and ultrasound examinations, as well as electrocardiography and other monitoring methods, has changed significantly due to the introduction of AI, particularly deep learning. Diagnostic accuracy has increased substantially, and predictive modeling of disease outcomes has become possible[31,32]. AI also has potential in diagnostics using positron emission tomography[33]. The use of AI substantially improves the diagnostic accuracy of panoramic tomographic examinations in dentistry[34]. AI, based on deep learning, significantly improves the accuracy of retinal optical coherence tomography analysis for cognitive impairment and neurodegenerative diseases, and may help monitor disease progression[35,36]. To improve the accuracy of ophthalmic diagnostics and glaucoma detection, it is necessary to use AI models[37]. Rehabilitation medicine aims to restore patients’ functions after various treatments and is especially important for postoperative care. Experience with AI-enabled robotic rehabilitation is likely to increase the effectiveness of rehabilitation medicine.

USING AI IN SUBJECTIVE METHODS OF PATIENT EXAMINATION

The use of AI has significant potential for interviewing patients to obtain information about the patient’s complaints, medical history and life history (medical biography). Medical interviews allow to reduce the time for questioning each patient and increase the accuracy of diagnosis[38,39]. AI-powered chatbot model GPT-4 can effectively interview patients on complaints and medical history. The GPT-4 model has the potential to be a versatile tool for use in various medical disciplines after deep learning[40]. The ChatGPT AI dialog model is a very effective way of maintaining medical records, including subjective methods of patient examination[41]. There is already successful experience using ChatGPT for assessing low back pain[42]. The ChatGPT can be successfully used for dynamic monitoring of a patient with diabetes mellitus[43]. The ChatGPT-4 model has the potential to be adapted to non-English speaking patients, in this sense it can be adapted to other languages[44]. A tablet computer can be a tool for patient communication with AI. Most patients prefer to use a tablet computer than to fill out a paper questionnaire[45]. The use of tablet computers by patients to collect medical anamnesis will make it much easier for doctors to obtain medical records[46]. The authors of a systematic review strongly support the use of AI for subjective assessment of patients in primary care[47]. AI models learn speech and text linguistic features, allowing them to be used in different languages[48]. Collecting patient information using a tablet computer is a widely used tool[49,50]. The results of many studies of conversational agents are characterized by contradictory results. Two-thirds of the studies have shown positive results from using AI models to dialogue with patients. There was no consensus on the effectiveness of different methods of patient dialogue and AI. However, the results of studying the capabilities of conversational agents can be assessed as promising for use in subjective diagnostics[51]. Voice chatbots have been successfully used during the Covid-19 pandemic. According to the authors, this experience of using voice AI was effective and high-quality in serving patients[52]. Conversational AI has been shown to be a positive force in providing care to patients with atrial fibrillation[53].

USING AI IN CLINICAL OBJECTIVE METHODS OF PATIENT EXAMINATION
General external examination (status praesens objectivus)

External examination is the cornerstone of the traditional physical examination. AI models employing computer vision can perform many components of the examination effectively. Routine clinical techniques can be supplemented or partly replaced by various sensors that complement existing medical practice. Such systems can capture traditional physical-examination maneuvers and assess phenotypic features (e.g., gait and posture). AI will facilitate the transition between in-office and remote monitoring by detecting changes in a patient’s clinical status in a timely manner[54].

Palpation

Based on the CASIT tactile-feedback system developed at the University of California, Los Angeles, various AI models can be developed to implement traditional patient palpation techniques. The CASIT system includes tactile sensors, a tactile controller, a driver, and actuators; using these components, it can determine the texture, rigidity, compliance, shape, and edges of tissues and organs[55].

Percussion

Ayodele et al[56] developed a device that can receive medical percussion sounds and analyze them using the MobileNetv2 convolutional neural network.

Auscultation

Auscultation is one of the primary methods of physical examination. AI-assisted auscultation has significant potential to improve diagnostic accuracy for many conditions. The DigitaLung project, a system employing deep learning and neural networks for lung auscultation, has the potential to enhance differential diagnosis in pulmonology[57]. An AI-enabled electronic stethoscope could substantially improve diagnostic efficiency in cardiology and cardiac surgery[58,59].

USING AI IN LABORATORY METHODS OF PATIENT EXAMINATION

The fundamentals of machine learning are being actively introduced into laboratory diagnostics, extending to routine clinical laboratory tests, biochemical analyses, and modern molecular-genetic studies[60,61]. Contemporary highly automated laboratory diagnostics, whose future development is closely linked to digital technologies, are likely to employ AI. The pace of development and implementation of future AI models in laboratory diagnostics depends on the intensity of cooperation between information-technology specialists and laboratory diagnosticians[62]. There is strong potential for AI in chemical laboratory research[63], and high expectations for its use in microbiological investigations[64]. Personalized medicine based on diagnostic genomics is impractical without AI, since the analysis of whole-genome sequencing data involves very large volumes of information[65]. AI is poised to revolutionize clinical laboratory diagnostics in line with the demands of personalized medicine[66,67]. According to participants at the Clinical Microbiology Conference held in Oceanside, California, on 1-2 February 2024, laboratory diagnostics using AI represents the “Laboratory of the Future”[68]. A revolutionary development is AI-assisted karyotyping in cytogenetics laboratories, which alters the paradigm of chromosome-analysis methodology[69].

AI in instrumental diagnostic methods

Technical progress in medical imaging for instrumental diagnostic examinations has achieved significant advances. Diagnostic methodology has been transformed by applying AI to modern visualization techniques for diverse pathological processes. This primarily concerns computed tomography and magnetic resonance imaging. AI is also used in diagnostic modalities such as electrocardiography, electroencephalography, electromyography, and ultrasonography[70-72]. The greatest diagnostic gains have been reported for AI-assisted endoscopic detection of pathological changes in the stomach[73-77] and colon[78,79]. AI applications in histopathological imaging have likewise proven highly effective[80-82].

DISCUSSION

Although experts predict a 5%-10% reduction in United States healthcare costs as a result of implementing AI in medicine, patient attitudes across 43 countries were mixed. The majority of respondents expressed a favorable view of digital technologies in medicine, but women were less positive than men: 73% preferred decisions to be made by a doctor[83]. The use of AI in diagnostics significantly increases the potential for predicting disease outcomes, treatment responses, and dynamic patient monitoring[84]. The development of personalized medicine and progress in robotic surgery depend largely on the extent of AI implementation[85-87]. In the future, AI technologies and models will cover all areas of medical activity, including biomedical research. At the same time, emotional and legal aspects of interactions between clinicians, patients, and AI must be carefully regulated[88-90]. A proposed general model of primary contact with a diagnostic algorithm is shown in Figure 1. According to the European Medicines Agency (EMA), leveraging the benefits of AI in healthcare requires significant support while simultaneously ensuring safety. Risks related to accountability, confidentiality, and bias must also be mitigated. The establishment of international-level training centers for effective experimentation is recommended as a promising way to overcome these contradictions. The operating principles of these training centers should be based on the support and development of AI products in medicine, in full compliance with legal and ethical regulations. The United States Food and Drug Administration (FDA) shares a similar view. The FDA emphasizes the need for strict oversight to ensure the safety, efficacy, and reliability of the use of AI models in medicine. To achieve promising goals, cause-and-effect relationships must be subject to feedback loops. Experimentation stimulates the development of a research program on tools and technologies. International collaboration will stimulate the creation of training programs and collaboration platforms based at training centers[91,92]. Modern personalized medicine is unthinkable without AI. The implementation of digital technologies by dividing patients into groups with similar characteristics will enable accurate diagnostics, targeted treatment, and prevention in a personalized medicine setting. Patient stratification using mechanistic models and machine learning will significantly facilitate diagnosis and treatment in personalized medicine. AI models make it possible to effectively structure the physiological mechanisms of diseases and identify patterns in large data sets. Model validation is crucial in this context. Collin et al[93] recommend the SPIRIT-AI and CONSORT-AI checklists as guidelines for reporting clinical trial data for digital models. They also recommend the AIMe registry for AI in biomedical research (https://aime-registry.org) to help developers of new machine learning models navigate data, methods, and reproducibility. The predictive capabilities of clinical medicine will significantly increase within the context of personalized medicine using digital technologies. For example, the introduction of a cancer signaling network atlas into practical oncology, which describes in detail the molecular and genetic mechanisms of cancer, will significantly improve the effectiveness of cancer prevention[93]. I would like to express my confidence that the recommendations proposed by Collin et al[93], as well as the recommendations of the EMA and FDA, will contribute to the development of precision digital medicine in the future. Human participation in digitally enabled systems offers promising potential for implementation in medicine. To implement such projects, Räz et al[94] propose a roadmap for the future of explainable AI in medicine. Explainable AI is constrained by two requirements. Explanatory information must be accurate and relevant. Explanations must also take into account the user’s level of professional training. For example, the level of a physician researcher and the level of a nurse require different explanations. A preliminary diagnosis generated by explainable AI, based on patient complaints, medical history, and physical data obtained using various sensors, must be explained in a way that takes into account the physician's experience and specialization. The use of language models will allow for the extraction and concise presentation of valuable patient information contained in voluminous medical records, thereby reducing the physician's cognitive load. The key question in this context is whether a full-fledged dialogue between humans and AI is possible. The use of large language models, such as ChatGPT, allows for a positive answer to this question. At this stage, such models are still inferior to traditional medical models. The ability of AI to analyze facial expressions, tone of voice, and communication characteristics allows us to assume a good dialogue prospect between the patient, doctor, and AI[94].

Figure 1
Figure 1 Future model of preventive, diagnostic and therapeutic prehospital care. AI: Artificial intelligence.
CONCLUSION

The diagnostic and therapeutic activities of the doctor are in competitive relations with the use of AI. Each of them has its own advantages and disadvantages. As a result of interaction, progress in medicine will become very dynamic.

References
1.  Gong EJ, Woo J, Lee JJ, Bang CS. Role of artificial intelligence in gastric diseases. World J Gastroenterol. 2025;31:111327.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 7]  [Reference Citation Analysis (1)]
2.  Wang YY, Liu B, Wang JH. Application of deep learning-based convolutional neural networks in gastrointestinal disease endoscopic examination. World J Gastroenterol. 2025;31:111137.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 7]  [Reference Citation Analysis (2)]
3.  Hamet P, Tremblay J. Artificial intelligence in medicine. Metabolism. 2017;69S:S36-S40.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1897]  [Cited by in RCA: 961]  [Article Influence: 106.8]  [Reference Citation Analysis (6)]
4.  Gou F, Liu J, Xiao C, Wu J. Research on Artificial-Intelligence-Assisted Medicine: A Survey on Medical Artificial Intelligence. Diagnostics (Basel). 2024;14:1472.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 36]  [Reference Citation Analysis (1)]
5.  Spinelli A, Carrano FM, Laino ME, Andreozzi M, Koleth G, Hassan C, Repici A, Chand M, Savevski V, Pellino G. Artificial intelligence in colorectal surgery: an AI-powered systematic review. Tech Coloproctol. 2023;27:615-629.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 31]  [Cited by in RCA: 24]  [Article Influence: 8.0]  [Reference Citation Analysis (4)]
6.  Kuris EO, Anderson GM, Alsoof D, Osorio C, Stone B, Basques B, Daniels AH. Robotic Spine Surgery in Rhode Island. R I Med J (2013). 2023;106:58-62.  [PubMed]  [DOI]
7.  De Simone B, Chouillard E, Gumbs AA, Loftus TJ, Kaafarani H, Catena F. Artificial intelligence in surgery: the emergency surgeon's perspective (the ARIES project). Discov Health Syst. 2022;1:9.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 2]  [Cited by in RCA: 15]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
8.  de'Angelis N, Khan J, Marchegiani F, Bianchi G, Aisoni F, Alberti D, Ansaloni L, Biffl W, Chiara O, Ceccarelli G, Coccolini F, Cicuttin E, D'Hondt M, Di Saverio S, Diana M, De Simone B, Espin-Basany E, Fichtner-Feigl S, Kashuk J, Kouwenhoven E, Leppaniemi A, Beghdadi N, Memeo R, Milone M, Moore E, Peitzmann A, Pessaux P, Pikoulis M, Pisano M, Ris F, Sartelli M, Spinoglio G, Sugrue M, Tan E, Gavriilidis P, Weber D, Kluger Y, Catena F. Robotic surgery in emergency setting: 2021 WSES position paper. World J Emerg Surg. 2022;17:4.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 84]  [Cited by in RCA: 82]  [Article Influence: 20.5]  [Reference Citation Analysis (0)]
9.  Soto Beauregard C, Rodríguez de Alarcón García J, Domínguez Amillo EE, Gómez Cervantes M, Ávila Ramírez LF. Implementing a pediatric robotic surgery program: future perspectives. Cir Pediatr. 2022;35:187-195.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
10.  Esperto F, Prata F, Antonelli A, Alloni R, Campanozzi L, Cataldo R, Civitella A, Fiori C, Ghilardi G, Guglielmelli E, Minervini A, Muto G, Rocco B, Sighinolfi C, Pang KH, Simone G, Tambone V, Tuzzolo P, Scarpa RM, Papalia R. Bioethical implications of robotic surgery in urology: a systematic review. Minerva Urol Nephrol. 2021;73:700-710.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 10]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
11.  Bozkurt E, Sijberden JP, Hilal MA. What Is the Current Role and What Are the Prospects of the Robotic Approach in Liver Surgery? Cancers (Basel). 2022;14:4268.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 8]  [Cited by in RCA: 25]  [Article Influence: 6.3]  [Reference Citation Analysis (0)]
12.  Song M, Liu Q, Guo H, Wang Z, Zhang H. Global trends and hotspots in robotic surgery over the past decade: a bibliometric and visualized analysis. J Robot Surg. 2024;19:33.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 13]  [Cited by in RCA: 16]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
13.  Sinha A, West A, Vasdev N, Sooriakumaran P, Rane A, Dasgupta P, McKirdy M. Current practises and the future of robotic surgical training. Surgeon. 2023;21:314-322.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 29]  [Reference Citation Analysis (0)]
14.  Tasoudis PT, Caranasos TG, Doulamis IP. Robotic applications for intracardiac and endovascular procedures. Trends Cardiovasc Med. 2024;34:110-117.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 4]  [Article Influence: 2.0]  [Reference Citation Analysis (0)]
15.  Choksi S, Szot S, Zang C, Yarali K, Cao Y, Ahmad F, Xiang Z, Bitner DP, Kostic Z, Filicori F. Bringing Artificial Intelligence to the operating room: edge computing for real-time surgical phase recognition. Surg Endosc. 2023;37:8778-8784.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 5]  [Cited by in RCA: 10]  [Article Influence: 3.3]  [Reference Citation Analysis (0)]
16.  von Reibnitz D, Weinzierl A, Barbon C, Gutschow CA, Giovanoli P, Grünherz L, Lindenblatt N. 100 anastomoses: a two-year single-center experience with robotic-assisted micro- and supermicrosurgery for lymphatic reconstruction. J Robot Surg. 2024;18:164.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 10]  [Cited by in RCA: 41]  [Article Influence: 20.5]  [Reference Citation Analysis (0)]
17.  Buyck F, Vandemeulebroucke J, Ceranka J, Van Gestel F, Cornelius JF, Duerinck J, Bruneau M. Computer-vision based analysis of the neurosurgical scene - A systematic review. Brain Spine. 2023;3:102706.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 8]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
18.  Barandiaran Cornejo JF, Chin LT, Angelis M. From Carrel to Robotics: Renal Transplantation and the Evolution of its Surgical Technique. Curr Urol Rep. 2025;26:38.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
19.  Tian H, Yin Y, Zhang X, Tan J, Liu J. Development and precision evaluation of a robotic system for oral implant surgery using personalized digital guides and optical spatial positioning technology. PLoS One. 2025;20:e0319054.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
20.  Doherty T, Yao Z, Khleifat AAL, Tantiangco H, Tamburin S, Albertyn C, Thakur L, Llewellyn DJ, Oxtoby NP, Lourida I; Deep Dementia Phenotyping (DEMON) Network, Ranson JM, Duce JA. Artificial intelligence for dementia drug discovery and trials optimization. Alzheimers Dement. 2023;19:5922-5933.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 7]  [Cited by in RCA: 24]  [Article Influence: 8.0]  [Reference Citation Analysis (0)]
21.  Armoundas AA, Ahmad FS, Attia ZI, Doudesis D, Khera R, Kyriakoulis KG, Stergiou GS, Tang WHW. Controversy in Hypertension: Pro-Side of the Argument Using Artificial Intelligence for Hypertension Diagnosis and Management. Hypertension. 2025;82:929-944.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 12]  [Cited by in RCA: 10]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
22.  Lo Gullo R, Marcus E, Huayanay J, Eskreis-Winkler S, Thakur S, Teuwen J, Pinker K. Artificial Intelligence-Enhanced Breast MRI: Applications in Breast Cancer Primary Treatment Response Assessment and Prediction. Invest Radiol. 2024;59:230-242.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 23]  [Cited by in RCA: 17]  [Article Influence: 8.5]  [Reference Citation Analysis (0)]
23.  Freedman B, Hindricks G, Banerjee A, Baranchuk A, Ching CK, Du X, Fitzsimons D, Healey JS, Ikeda T, Lobban TCA, Mbakwem A, Narasimhan C, Neubeck L, Noseworthy P, Philbin DM Jr, Pinto FJ, Rwebembera J, Schnabel RB, Svendsen JH, Aguinaga L, Arbelo E, Böhm M, Farhan HA, Hobbs FDR, Martínez-Rubio A, Militello C, Naik N, Noubiap JJ, Perel P, Piñeiro DJ, Ribeiro AL, Stepinska J. World Heart Federation Roadmap on Atrial Fibrillation - A 2020 Update. Glob Heart. 2021;16:41.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 50]  [Cited by in RCA: 64]  [Article Influence: 12.8]  [Reference Citation Analysis (2)]
24.  Halagali P, Nayak D, Seenivasan R, Manikkath J, Rathnanand M, Tippavajhala VK. Artificial Intelligence Revolution in Pharmaceutical Sciences: Advancements, Clinical Impacts, and Applications. Curr Pharm Biotechnol.  2025.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
25.  Chong LM, Wang P, Lee VV, Vijayakumar S, Tan HQ, Wang FQ, Yeoh TDYY, Truong ATL, Tan LWJ, Tan SB, Senthil Kumar K, Hau E, Vellayappan BA, Blasiak A, Ho D. Radiation therapy with phenotypic medicine: towards N-of-1 personalization. Br J Cancer. 2024;131:1-10.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 8]  [Cited by in RCA: 7]  [Article Influence: 3.5]  [Reference Citation Analysis (0)]
26.  Brewer KD, Santo NV, Samanta A, Nag R, Trotsyuk AA, Rajadas J. Advances in Therapeutics for Chronic Lung Diseases: From Standard Therapies to Emerging Breakthroughs. J Clin Med. 2025;14:3118.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
27.  Saini G, Joshi S, Garlapati C, Li H, Kong J, Krishnamurthy J, Reid MD, Aneja R. Polyploid giant cancer cell characterization: New frontiers in predicting response to chemotherapy in breast cancer. Semin Cancer Biol. 2022;81:220-231.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 31]  [Cited by in RCA: 50]  [Article Influence: 12.5]  [Reference Citation Analysis (0)]
28.  Vashistha V, Armstrong J, Winski D, Poonnen PJ, Hintze B, Price M, Snowdon JL, Weeraratne D, Brotman D, Jackson GP, Kelley MJ. Barriers to Prescribing Targeted Therapies for Patients With NSCLC With Highly Actionable Gene Variants in the Veterans Affairs National Precision Oncology Program. JCO Oncol Pract. 2021;17:e1012-e1020.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 17]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
29.  Düvel JA, Lampe D, Kirchner M, Elkenkamp S, Cimiano P, Düsing C, Marchi H, Schmiegel S, Fuchs C, Claßen S, Meier KL, Borgstedt R, Rehberg S, Greiner W. An AI-Based Clinical Decision Support System for Antibiotic Therapy in Sepsis (KINBIOTICS): Use Case Analysis. JMIR Hum Factors. 2025;12:e66699.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 24]  [Cited by in RCA: 15]  [Article Influence: 15.0]  [Reference Citation Analysis (0)]
30.  Podder D, Stala O, Hirani R, Karp AM, Etienne M. Comprehensive Approaches to Pain Management in Postoperative Spinal Surgery Patients: Advanced Strategies and Future Directions. Neurol Int. 2025;17:94.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 6]  [Cited by in RCA: 18]  [Article Influence: 18.0]  [Reference Citation Analysis (0)]
31.  Maniaci A, Lavalle S, Gagliano C, Lentini M, Masiello E, Parisi F, Iannella G, Cilia ND, Salerno V, Cusumano G, La Via L. The Integration of Radiomics and Artificial Intelligence in Modern Medicine. Life (Basel). 2024;14:1248.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 44]  [Reference Citation Analysis (0)]
32.  Belenkov YN, Kozhevnikova MV, Khabarova NV, Ilgisonis IS, Korobkova EO. The Role of Artificial Intelligence in Cardiology. Kardiologiia. 2025;65:3-16.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
33.  Zukotynski KA, Gaudet VC, Uribe CF, Chiam K, Bénard F, Gerbaudo VH. Clinical Applications of Artificial Intelligence in Positron Emission Tomography of Lung Cancer. PET Clin. 2022;17:77-84.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 8]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
34.  Zaborowicz K, Zaborowicz M, Cieślińska K, Daktera-Micker A, Firlej M, Biedziak B. Artificial Intelligence Methods in the Detection of Oral Diseases on Pantomographic Images-A Systematic Narrative Review. J Clin Med. 2025;14:3262.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
35.  Rauscher FG, Bernardes R. [Retinal optical coherence tomography biomarkers and their association with cognitive functions : Clinical and artificial intelligence approaches. German version]. Ophthalmologie. 2024;121:105-115.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
36.  Rauscher FG, Bernardes R. Retinal OCT biomarkers and their association with cognitive function-clinical and AI approaches. Ophthalmologie. 2025;122:20-28.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
37.  Ghaffar F, Furtado NM, Ali I, Burns C. Diagnostic Decision-Making Variability Between Novice and Expert Optometrists for Glaucoma: Comparative Analysis to Inform AI System Design. JMIR Med Inform. 2025;13:e63109.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 6]  [Cited by in RCA: 4]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
38.  Miller BA, Adhikari B, Jiang C, Novak VD. Automated patient-robot assignment for a robotic rehabilitation gym: a simplified simulation model. J Neuroeng Rehabil. 2022;19:126.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
39.  Kanazawa A, Fujibayashi K, Watanabe Y, Kushiro S, Yanagisawa N, Fukataki Y, Kitamura S, Hayashi W, Nagao M, Nishizaki Y, Inomata T, Arikawa-Hirasawa E, Naito T. Evaluation of a Medical Interview-Assistance System Using Artificial Intelligence for Resident Physicians Interviewing Simulated Patients: A Crossover, Randomized, Controlled Trial. Int J Environ Res Public Health. 2023;20:6176.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 7]  [Reference Citation Analysis (0)]
40.  Rädel-Ablass K, Schliz K, Schlick C, Meindl B, Pahr-Hosbach S, Schwendemann H, Rupp S, Roddewig M, Miersch C. Teaching opportunities for anamnesis interviews through AI based teaching role plays: a survey with online learning students from health study programs. BMC Med Educ. 2025;25:259.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 13]  [Reference Citation Analysis (0)]
41.  Baker HP, Dwyer E, Kalidoss S, Hynes K, Wolf J, Strelzow JA. ChatGPT's Ability to Assist with Clinical Documentation: A Randomized Controlled Trial. J Am Acad Orthop Surg. 2024;32:123-129.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 26]  [Cited by in RCA: 58]  [Article Influence: 29.0]  [Reference Citation Analysis (0)]
42.  Coraci D, Maccarone MC, Regazzo G, Accordi G, Papathanasiou JV, Masiero S. ChatGPT in the development of medical questionnaires. The example of the low back pain. Eur J Transl Myol. 2023;33:12114.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4]  [Cited by in RCA: 15]  [Article Influence: 5.0]  [Reference Citation Analysis (0)]
43.  Alanzi TM, Arif W, Alotaibi A, Alnafisi A, Alhwaimal R, Altowairqi N, Alnifaie A, Aldossari K, Althumali K, Alanzi N. Impact of ChatGPT on Diabetes Mellitus Self-Management Among Patients in Saudi Arabia. Cureus. 2025;17:e81855.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
44.  Sakaguchi K, Sakama R, Watari T. Evaluating ChatGPT in Qualitative Thematic Analysis With Human Researchers in the Japanese Clinical Context and Its Cultural Interpretation Challenges: Comparative Qualitative Study. J Med Internet Res. 2025;27:e71521.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 11]  [Reference Citation Analysis (0)]
45.  Melms L, Schaefer JR, Jerrentrup A, Mueller T. A pilot study of patient satisfaction with a self-completed tablet-based digital questionnaire for collecting the patient's medical history in an emergency department. BMC Health Serv Res. 2021;21:755.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1]  [Cited by in RCA: 18]  [Article Influence: 3.6]  [Reference Citation Analysis (0)]
46.  Hauber R, Schirm M, Lukas M, Reitelbach C, Brenig J, Breunig M, Brenner S, Störk S, Puppe F. Computer-assisted medical history taking prior to patient consultation in the outpatient care setting: a prospective pilot project. BMC Health Serv Res. 2024;24:1616.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
47.  Martínez-Martínez H, Martínez-Alfonso J, Sánchez-Rojo-Huertas B, Reynolds-Cortez V, Turégano-Chumillas A, Meseguer-Ruiz VA, Cekrezi S, Martínez-Vizcaíno V. Perceptions of, Barriers to, and Facilitators of the Use of AI in Primary Care: Systematic Review of Qualitative Studies. J Med Internet Res. 2025;27:e71186.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 1]  [Cited by in RCA: 10]  [Article Influence: 10.0]  [Reference Citation Analysis (0)]
48.  Lim E, Jhon M, Kim JW, Kim SH, Kim S, Yang HJ. A lightweight approach based on cross-modality for depression detection. Comput Biol Med. 2025;186:109618.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 12]  [Cited by in RCA: 5]  [Article Influence: 5.0]  [Reference Citation Analysis (1)]
49.  Weigel S, Backhaus J, Grunz JP, Kunz AS, Bley TA, König S. Tablet-based versus presentation-based seminars in radiology: Effects of student digital affinity and teacher charisma on didactic quality. GMS J Med Educ. 2023;40:Doc59.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
50.  Mir H, Cullen KJ, Mosleh K, Setrak R, Jolly S, Tsang M, Rutledge G, Ibrahim Q, Welsford M, Mercuri M, Schwalm JD, Natarajan MK. Smartphone App for Prehospital ECG Transmission in ST-Elevation Myocardial Infarction Activation: Protocol for a Mixed Methods Study. JMIR Res Protoc. 2024;13.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 8]  [Reference Citation Analysis (0)]
51.  Milne-Ives M, de Cock C, Lim E, Shehadeh MH, de Pennington N, Mole G, Normando E, Meinert E. The Effectiveness of Artificial Intelligence Conversational Agents in Health Care: Systematic Review. J Med Internet Res. 2020;22:e20346.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 229]  [Cited by in RCA: 293]  [Article Influence: 48.8]  [Reference Citation Analysis (0)]
52.  Jadczyk T, Wojakowski W, Tendera M, Henry TD, Egnaczyk G, Shreenivas S. Artificial Intelligence Can Improve Patient Management at the Time of a Pandemic: The Role of Voice Technology. J Med Internet Res. 2021;23:e22959.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 9]  [Cited by in RCA: 41]  [Article Influence: 8.2]  [Reference Citation Analysis (0)]
53.  Trivedi R, Shaw T, Sheahen B, Chow CK, Laranjo L. Patient Perspectives on Conversational Artificial Intelligence for Atrial Fibrillation Self-Management: Qualitative Analysis. J Med Internet Res. 2025;27:e64325.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 11]  [Reference Citation Analysis (0)]
54.  Oikonomou EK, Khera R. Artificial intelligence-enhanced patient evaluation: bridging art and science. Eur Heart J. 2024;45:3204-3218.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 12]  [Cited by in RCA: 23]  [Article Influence: 11.5]  [Reference Citation Analysis (0)]
55.  Ouyang Q, Wu J, Sun S, Pensa J, Abiri A, Dutson E, Bisley J. Bio-Inspired Haptic Feedback for Artificial Palpation in Robotic Surgery. IEEE Trans Biomed Eng. 2021;68:3184-3193.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 17]  [Article Influence: 3.4]  [Reference Citation Analysis (0)]
56.  Ayodele KP, Ogunlade O, Olugbon OJ, Akinwale OB, Kehinde LO. A medical percussion instrument using a wavelet-based method for archivable output and automatic classification. Comput Biol Med. 2020;127:104100.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4]  [Cited by in RCA: 4]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]
57.  Hilberink L, Wehage P, Pashai Fakhri M, Gaedcke S, DeLuca D, Mattis P, Rademacher J. [Artificial intelligence and machine learning in auscultation: prospects of the project DigitaLung]. Pneumologie. 2025;79:229-235.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 1]  [Reference Citation Analysis (0)]
58.  Xu W, Yu K, Xu J, Ye J, Li H, Shu Q. [Artificial intelligence technology in cardiac auscultation screening for congenital heart disease: present and future]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49:548-555.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
59.  Long Q, Ye X, Zhao Q. Artificial intelligence and automation in valvular heart diseases. Cardiol J. 2020;27:404-420.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 2]  [Cited by in RCA: 16]  [Article Influence: 2.7]  [Reference Citation Analysis (0)]
60.  Baron JM. Artificial Intelligence in the Clinical Laboratory. Clin Lab Med. 2023;43:ix-ix.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
61.  Baron JM. Artificial Intelligence in the Clinical Laboratory: An Overview with Frequently Asked Questions. Clin Lab Med. 2023;43:1-16.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
62.  Hou H, Zhang R, Li J. Artificial intelligence in the clinical laboratory. Clin Chim Acta. 2024;559:119724.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 21]  [Reference Citation Analysis (0)]
63.  Bunch DR, Durant TJ, Rudolf JW. Artificial Intelligence Applications in Clinical Chemistry. Clin Lab Med. 2023;43:47-69.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 12]  [Reference Citation Analysis (0)]
64.  Burns BL, Rhoads DD, Misra A. The Use of Machine Learning for Image Analysis Artificial Intelligence in Clinical Microbiology. J Clin Microbiol. 2023;61:e0233621.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 29]  [Article Influence: 9.7]  [Reference Citation Analysis (0)]
65.  Aradhya S, Facio FM, Metz H, Manders T, Colavin A, Kobayashi Y, Nykamp K, Johnson B, Nussbaum RL. Applications of artificial intelligence in clinical laboratory genomics. Am J Med Genet C Semin Med Genet. 2023;193:e32057.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 11]  [Cited by in RCA: 35]  [Article Influence: 11.7]  [Reference Citation Analysis (0)]
66.  Ashraf AA, Rai S, Alva S, Alva PD, Naresh S. Revolutionizing clinical laboratories: The impact of artificial intelligence in diagnostics and patient care. Diagn Microbiol Infect Dis. 2025;111:116728.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
67.  Dodig S, Čepelak I, Dodig M. Are we ready to integrate advanced artificial intelligence models in clinical laboratory? Biochem Med (Zagreb). 2025;35:010501.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 13]  [Reference Citation Analysis (0)]
68.  Dien Bard J, Prinzi AM, Larkin PM, Peaper DR, Rhoads DD. Proceedings of the Clinical Microbiology Open 2024: artificial intelligence applications in clinical microbiology. J Clin Microbiol. 2025;63:e0180424.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 16]  [Cited by in RCA: 16]  [Article Influence: 16.0]  [Reference Citation Analysis (0)]
69.  Rosenblum LS, Holmes J, Taghiyev AF. The Emergence of Artificial Intelligence-Guided Karyotyping: A Review and Reflection. Genes (Basel). 2025;16:685.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 7]  [Reference Citation Analysis (0)]
70.  Al-Antari MA. Artificial Intelligence for Medical Diagnostics-Existing and Future AI Technology! Diagnostics (Basel). 2023;13:688.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 63]  [Reference Citation Analysis (1)]
71.  Khalifa M, Albadawy M. AI in diagnostic imaging: Revolutionising accuracy and efficiency. Compu Meth Progr Biomed Update. 2024;5:100146.  [PubMed]  [DOI]  [Full Text]
72.  Gore JC. Artificial intelligence in medical imaging. Magn Reson Imaging. 2020;68:A1-A4.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 222]  [Cited by in RCA: 150]  [Article Influence: 25.0]  [Reference Citation Analysis (0)]
73.  Miura Y, Osawa H, Sugano K. Recent Progress of Image-Enhanced Endoscopy for Upper Gastrointestinal Neoplasia and Associated Lesions. Dig Dis. 2024;42:186-198.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 9]  [Cited by in RCA: 11]  [Article Influence: 3.7]  [Reference Citation Analysis (0)]
74.  Yuan P, Ma ZH, Yan Y, Li SJ, Wang J, Wu Q. Artificial Intelligence-Based Classification of Anatomical Sites in Esophagogastroduodenoscopy Images. Int J Gen Med. 2024;17:6127-6138.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 4]  [Cited by in RCA: 3]  [Article Influence: 1.5]  [Reference Citation Analysis (3)]
75.  Horiuchi Y, Hirasawa T, Fujisaki J. Application of artificial intelligence for diagnosis of early gastric cancer based on magnifying endoscopy with narrow-band imaging. Clin Endosc. 2024;57:11-17.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 14]  [Cited by in RCA: 14]  [Article Influence: 7.0]  [Reference Citation Analysis (0)]
76.  Kikuchi R, Okamoto K, Ozawa T, Shibata J, Ishihara S, Tada T. Endoscopic Artificial Intelligence for Image Analysis in Gastrointestinal Neoplasms. Digestion. 2024;105:419-435.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 18]  [Cited by in RCA: 15]  [Article Influence: 7.5]  [Reference Citation Analysis (0)]
77.  Matsubayashi CO, Cheng S, Hulchafo I, Zhang Y, Tada T, Buxbaum JL, Ochiai K. Artificial intelligence for gastric cancer in endoscopy: From diagnostic reasoning to market. Dig Liver Dis. 2024;56:1156-1163.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 10]  [Cited by in RCA: 11]  [Article Influence: 5.5]  [Reference Citation Analysis (0)]
78.  Wei MT, Fay S, Yung D, Ladabaum U, Kopylov U. Artificial Intelligence-Assisted Colonoscopy in Real-World Clinical Practice: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol. 2024;15:e00671.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 48]  [Cited by in RCA: 46]  [Article Influence: 23.0]  [Reference Citation Analysis (0)]
79.  Halvorsen N, Mori Y. Cost-Effectiveness for Artificial Intelligence in Colonoscopy. Gastrointest Endosc Clin N Am. 2025;35:401-405.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
80.  Liu H, Ying L, Song X, Xiang X, Wei S. Development of metastasis and survival prediction model of luminal and non-luminal breast cancer with weakly supervised learning based on pathomics. PeerJ. 2025;13:e18780.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 4]  [Cited by in RCA: 4]  [Article Influence: 4.0]  [Reference Citation Analysis (1)]
81.  Li M, Shen ZL, Xian HC, Zheng ZJ, Yu ZW, Liang XH, Gao R, Tang YL, Zhang Z. A Recognition System for Diagnosing Salivary Gland Neoplasms Based on Vision Transformer. Am J Pathol. 2025;195:221-231.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 5]  [Cited by in RCA: 6]  [Article Influence: 6.0]  [Reference Citation Analysis (0)]
82.  Zhang F, Shen Z, Huang S, Zhu Y, Yi M. SpaInGNN: Enhanced clustering and integration of spatial transcriptomics based on refined graph neural networks. Methods. 2025;233:42-51.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 1]  [Cited by in RCA: 3]  [Article Influence: 3.0]  [Reference Citation Analysis (1)]
83.  Busch F, Hoffmann L, Xu L, Zhang LJ, Hu B, García-Juárez I, Toapanta-Yanchapaxi LN, Gorelik N, Gorelik V, Rodriguez-Granillo GA, Ferrarotti C, Cuong NN, Thi CAP, Tuncel M, Kaya G, Solis-Barquero SM, Mendez Avila MC, Ivanova NG, Kitamura FC, Hayama KYI, Puntunet Bates ML, Torres PI, Ortiz-Prado E, Izquierdo-Condoy JS, Schwarz GM, Hofstaetter JG, Hide M, Takeda K, Peric B, Pilko G, Thulesius HO, Lindow T, Kolawole IK, Olatoke SA, Grzybowski A, Corlateanu A, Iaconi OS, Li T, Domitrz I, Kepczynska K, Mihalcin M, Fašaneková L, Zatonski T, Fulek K, Molnár A, Maihoub S, da Silva Gama ZA, Saba L, Sountoulides P, Makowski MR, Aerts HJWL, Adams LC, Bressem KK; COMFORT consortium, Navarro ÁA, Águas C, Aineseder M, Alomar M, Al Sliman R, Anand G, Angkurawaranon S, Aoki S, Arkoh S, Ashraf G, Astri Y, Bakhshi S, Bayramov NY, Billis A, Bitencourt AGV, Bolejko A, Bollas Becerra AJ, Bwambale J, Capela A, Cau R, Chacon-Acevedo KR, Chaunzwa TL, Chojniak R, Clements W, Cuocolo R, Dahlblom V, Sousa KM, Villarrubia JE, Desai VB, Dhakal AK, Dignum V, Andrade RGF, Ferraioli G, Ganguly S, Garg H, Savevska CG, Radovikj MG, Gkartzoni A, Gorospe L, Griffin I, Hadamitzky M, Ndahiro MH, Hering A, Hochhegger B, Huseynova MR, Ishida F, Jha N, Jiang L, Kader R, Kavnoudias H, Klein C, Kolostoumpis G, Koshy A, Kruger NA, Löser A, Lucijanic M, Mantziari D, Margue G, McFadden S, Miyake M, Morakote W, Ngabonziza I, Nguyen TT, Niehues SM, Nortje M, Palaian S, Pentara NV, de Almeida RPP, Poma G, Purwoko M, Pyrgidis N, Rafailidis V, Rainey C, Ribeiro JC, Agudelo NR, Sado K, Saidman JM, Saturno-Hernandez PJ, Suryadevara V, Schulz GB, Soric E, Soto-Pérez-Olivares J, Stanzione A, Struck JP, Takaoka H, Tanioka S, Huyen TTM, Truhn D, van Dijk EHC, van Wijngaarden P, Wang YC, Weidlich M, Zhang S. Multinational Attitudes Toward AI in Health Care and Diagnostics Among Hospital Patients. JAMA Netw Open. 2025;8:e2514452.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 45]  [Reference Citation Analysis (0)]
84.  Kauttonen J, Rousi R, Alamäki A. Trust and Acceptance Challenges in the Adoption of AI Applications in Health Care: Quantitative Survey Analysis. J Med Internet Res. 2025;27:e65567.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 35]  [Reference Citation Analysis (0)]
85.  Deivayanai VC, Swaminaathanan P, Vickram AS, Saravanan A, Bibi S, Aggarwal N, Kumar V, Alhadrami AH, Mohammedsaleh ZM, Altalhi R, Nasser Bin-Jumah M, Sayed AA, Albaqami A, Chopra H, Emran TB, Abdel-Daim MM. Transforming healthcare: the impact of artificial intelligence on diagnostics, pharmaceuticals, and ethical considerations - a comprehensive review. Int J Surg. 2025;111:4666-4693.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 5]  [Reference Citation Analysis (0)]
86.  Hiraoka A, Swinnen B, Vandeputte A, Franssen W, Leirs G. Optimizing operating room efficiency in robotic-assisted total knee arthroplasty through manufacturing efficiency principles. J Exp Orthop. 2025;12:e70283.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
87.  Krauss DT, Fuchs HF, Schaaf S, Drossard S, Rösch R, Blank B, Bruns CJ, Rolle U, Schmitz-Rixen T, Kröplin J. [Is the application of digital technologies the game changer for surgical training of the future? A Germany-wide analysis]. Chirurgie (Heidelb). 2025;96:755-764.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in RCA: 3]  [Reference Citation Analysis (0)]
88.  Choubey A, Choubey SB, K P, Daulatabad VS, John N. Healthcare Transformation: Artificial Intelligence Is the Dire Imperative of the Day. Cureus. 2024;16:e62652.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 4]  [Reference Citation Analysis (0)]
89.  Smoła P, Młoźniak I, Wojcieszko M, Zwierczyk U, Kobryn M, Rzepecka E, Duplaga M. Attitudes toward artificial intelligence and robots in healthcare in the general population: a qualitative study. Front Digit Health. 2025;7:1458685.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 6]  [Reference Citation Analysis (0)]
90.  Mathews Maluvelil A, Keshavjee K. Regulating Innovation: Addressing the Challenges of Canada's Health-Tech Sector. Stud Health Technol Inform. 2025;322:91-92.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 2]  [Reference Citation Analysis (0)]
91.  Correia Pinheiro L, Arlett P, Roes K, Musuamba Tshinanu F, Westman G, Frias Z, Hamann H, Berenguer Jornet J, Khan I, Larsen J, Broich K, Cooke E. Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health. Clin Pharmacol Ther. 2025;117:335-336.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in RCA: 8]  [Reference Citation Analysis (0)]
92.  Warraich HJ, Tazbaz T, Califf RM. FDA Perspective on the Regulation of Artificial Intelligence in Health Care and Biomedicine. JAMA. 2025;333:241-247.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Cited by in Crossref: 207]  [Cited by in RCA: 197]  [Article Influence: 197.0]  [Reference Citation Analysis (2)]
93.  Collin CB, Gebhardt T, Golebiewski M, Karaderi T, Hillemanns M, Khan FM, Salehzadeh-Yazdi A, Kirschner M, Krobitsch S;  Eu-Stands Pm Consortium; Kuepfer L. Computational Models for Clinical Applications in Personalized Medicine-Guidelines and Recommendations for Data Integration and Model Validation. J Pers Med. 2022;12:166.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 2]  [Cited by in RCA: 53]  [Article Influence: 13.3]  [Reference Citation Analysis (0)]
94.  Räz T, Pahud De Mortanges A, Reyes M. Explainable AI in medicine: challenges of integrating XAI into the future clinical routine. Front Radiol. 2025;5:1627169.  [RCA]  [PubMed]  [DOI]  [Full Text]  [Full Text (PDF)]  [Cited by in Crossref: 6]  [Cited by in RCA: 20]  [Article Influence: 20.0]  [Reference Citation Analysis (0)]
Footnotes

Peer review: Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Computer science, artificial intelligence

Country of origin: Russia

Peer-review report’s classification

Scientific quality: Grade B, Grade B

Novelty: Grade B, Grade B

Creativity or innovation: Grade B, Grade B

Scientific significance: Grade B, Grade B

P-Reviewer: Li Y, MD, China S-Editor: Liu H L-Editor: A P-Editor: Xu ZH

Write to the Help Desk